1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type (2015-2028)
1.4.2 Oncology
1.4.3 Infectious Diseases
1.4.4 Rare Diseases
1.4.5 Autoimmune Diseases
1.4.6 Pulmonary Diseases
1.4.7 Neurological Disorders
1.4.8 Others
1.5 Market by Application
1.5.1 Global Breakthrough Therapy (BT) Designation Market Share by Application (2015-2028)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Breakthrough Therapy (BT) Designation Market Size
2.2 Breakthrough Therapy (BT) Designation Growth Trends by Regions
2.2.1 Breakthrough Therapy (BT) Designation Market Size by Regions (2015-2028)
2.2.2 Breakthrough Therapy (BT) Designation Market Share by Regions (2015-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Breakthrough Therapy (BT) Designation Market Size by Manufacturers
3.1.1 Global Breakthrough Therapy (BT) Designation Revenue by Manufacturers (2015-2020)
3.1.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Manufacturers (2015-2020)
3.1.3 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio (CR5 and HHI)
3.2 Breakthrough Therapy (BT) Designation Key Players Head office and Area Served
3.3 Key Players Breakthrough Therapy (BT) Designation Product/Solution/Service
3.4 Date of Enter into Breakthrough Therapy (BT) Designation Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Breakthrough Therapy (BT) Designation Market Size by Type (2015-2020)
4.2 Global Breakthrough Therapy (BT) Designation Market Size by Application (2015-2020)
5 United States
5.1 United States Breakthrough Therapy (BT) Designation Market Size (2015-2020)
5.2 Breakthrough Therapy (BT) Designation Key Players in United States
5.3 United States Breakthrough Therapy (BT) Designation Market Size by Type
5.4 United States Breakthrough Therapy (BT) Designation Market Size by Application
6 Europe
6.1 Europe Breakthrough Therapy (BT) Designation Market Size (2015-2020)
6.2 Breakthrough Therapy (BT) Designation Key Players in Europe
6.3 Europe Breakthrough Therapy (BT) Designation Market Size by Type
6.4 Europe Breakthrough Therapy (BT) Designation Market Size by Application
7 China
7.1 China Breakthrough Therapy (BT) Designation Market Size (2015-2020)
7.2 Breakthrough Therapy (BT) Designation Key Players in China
7.3 China Breakthrough Therapy (BT) Designation Market Size by Type
7.4 China Breakthrough Therapy (BT) Designation Market Size by Application
8 Japan
8.1 Japan Breakthrough Therapy (BT) Designation Market Size (2015-2020)
8.2 Breakthrough Therapy (BT) Designation Key Players in Japan
8.3 Japan Breakthrough Therapy (BT) Designation Market Size by Type
8.4 Japan Breakthrough Therapy (BT) Designation Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Breakthrough Therapy (BT) Designation Market Size (2015-2020)
9.2 Breakthrough Therapy (BT) Designation Key Players in Southeast Asia
9.3 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Type
9.4 Southeast Asia Breakthrough Therapy (BT) Designation Market Size by Application
10 India
10.1 India Breakthrough Therapy (BT) Designation Market Size (2015-2020)
10.2 Breakthrough Therapy (BT) Designation Key Players in India
10.3 India Breakthrough Therapy (BT) Designation Market Size by Type
10.4 India Breakthrough Therapy (BT) Designation Market Size by Application
11 Central & South America
11.1 Central & South America Breakthrough Therapy (BT) Designation Market Size (2015-2020)
11.2 Breakthrough Therapy (BT) Designation Key Players in Central & South America
11.3 Central & South America Breakthrough Therapy (BT) Designation Market Size by Type
11.4 Central & South America Breakthrough Therapy (BT) Designation Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Breakthrough Therapy (BT) Designation Introduction
12.1.4 Roche Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.1.5 Roche Recent Development
12.2 Abbvie
12.2.1 Abbvie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Breakthrough Therapy (BT) Designation Introduction
12.2.4 Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.2.5 Abbvie Recent Development
12.3 Novartis International AG
12.3.1 Novartis International AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Breakthrough Therapy (BT) Designation Introduction
12.3.4 Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.3.5 Novartis International AG Recent Development
12.4 Janssen
12.4.1 Janssen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Breakthrough Therapy (BT) Designation Introduction
12.4.4 Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.4.5 Janssen Recent Development
12.5 BMS
12.5.1 BMS Company Details
12.5.2 Company Description and Business Overview
12.5.3 Breakthrough Therapy (BT) Designation Introduction
12.5.4 BMS Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.5.5 BMS Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Company Details
12.6.2 Company Description and Business Overview
12.6.3 Breakthrough Therapy (BT) Designation Introduction
12.6.4 Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.6.5 Eli Lilly Recent Development
12.7 Gilead
12.7.1 Gilead Company Details
12.7.2 Company Description and Business Overview
12.7.3 Breakthrough Therapy (BT) Designation Introduction
12.7.4 Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.7.5 Gilead Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Breakthrough Therapy (BT) Designation Introduction
12.8.4 Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.8.5 Sanofi Recent Development
12.9 Regeneron
12.9.1 Regeneron Company Details
12.9.2 Company Description and Business Overview
12.9.3 Breakthrough Therapy (BT) Designation Introduction
12.9.4 Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.9.5 Regeneron Recent Development
12.10 Acadia
12.10.1 Acadia Company Details
12.10.2 Company Description and Business Overview
12.10.3 Breakthrough Therapy (BT) Designation Introduction
12.10.4 Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2015-2020)
12.10.5 Acadia Recent Development
12.11 Boehringer Ingelheim
12.12 Amgen
12.13 AstraZeneca
12.14 GlaxoSmithKline
12.15 Vertex
12.16 Alexion
12.17 Merck
12.18 Jazz Pharmaceuticals
12.19 Exelixis
12.20 Eisai
12.21 Takeda
12.22 Pfizer
13 Market Forecast 2021-2028
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2028)
13.10 Market Size Forecast by Application (2021-2028)
14 Analysts Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details